WPG Advisers’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$862 Hold
55
﹤0.01% 1360
2026
Q1
$551 Sell
55
-131
-70% -$1.94K ﹤0.01% 1352
2025
Q4
$5.67K Hold
186
﹤0.01% 871
2025
Q3
$3.7K Hold
186
﹤0.01% 985
2025
Q2
$2.71K Buy
186
+158
+564% +$2.24K ﹤0.01% 1048
2025
Q1
$343 Buy
+28
New +$522 ﹤0.01% 1378

Other funds holding BBNX

WPG Advisers's BBNX Position: Q2 2026 in Review

WPG Advisers held its Beta Bionics (BBNX) position steady in Q2 2026 at 55 shares worth $862. The position accounts for ﹤0.01% of the portfolio, ranked #1360.

WPG Advisers first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.67K in Q4 2025. 43 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • WPG Advisers held 55 shares of Beta Bionics worth $862 as of Q2 2026.
  • WPG Advisers left its Beta Bionics share count unchanged in Q2 2026.
  • Beta Bionics made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1360 holding.
  • WPG Advisers first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • WPG Advisers's Beta Bionics position peaked at $5.67K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.